Target intelligence / Profile preview

MicroRNA 548x-2 (miR-548x-2)

Target
miR-548x-2
Molecular classification
MicroRNA, Non-coding RNA, Gene regulatory RNA
01

Overview

MicroRNA 548x-2 (miR-548x-2, MIR548X2) is a predicted, non-coding RNA of the primate-specific microRNA-548 family, which are known to post-transcriptionally regulate gene expression. No substantial, experimentally confirmed biological role, disease association, or therapeutic relevance has been reported for miR-548x-2 specifically. Most available data on the miR-548 family concern other family members, such as miR-548m and miR-548j, which have shown involvement in cancer cell proliferation, migration, and invasion, but these findings cannot be extrapolated with confidence to miR-548x-2. In summary, MicroRNA 548x-2 is a poorly characterized and possibly nonvalidated microRNA; the available evidence is insufficient to classify it as a well-established therapeutic or disease-related target. Most information pertains to other miR-548 family members, and little to miR-548x-2 directly.

Other names
hsa-mir-548x-2MIR548X2miRNA-548x-2MicroRNA 548x-2
02

Mechanism of action

Not known for miR-548x-2. Generally, miRNAs work by binding to complementary mRNA sequences, resulting in mRNA degradation or inhibition of translation, thereby suppressing gene expression. Potentially, miRNA mimics or inhibitors could modulate its activity if validated.

03

Biological functions

Gene expression/post-transcriptional regulation by RNA interferenceControl of cell proliferation and apoptosisPotential regulation of tumor suppressor and oncogenic pathways
04

Disease associations

Cancer, including breast cancer (various members act as tumor suppressors or promoters)GlioblastomaNo direct evidence available for "microRNA 548x-2" in any disease.
05

Safety considerations

Not established for this specific microRNA.General challenges for miRNA-based therapy include: off-target effects, stability, delivery, and the risk of immune activation.
06

Interacting drugs

None known for miR-548x-2. No direct drugs or chemical modulators identified.
07

Biomarkers

None reported for miR-548x-2.Other miR-548 family members (e.g., miR-548m) have been suggested as biomarkers in breast cancer.

Beyond the preview

Go deeper on MicroRNA 548x-2 (miR-548x-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 548x-2 (miR-548x-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call